Pure Global

RAMP CK-MB Assay - Taiwan Registration 5ec4b2ac2e400545d356b9ccf8070de6

Access comprehensive regulatory information for RAMP CK-MB Assay in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5ec4b2ac2e400545d356b9ccf8070de6 and manufactured by RESPONSE BIOMEDICAL CORPORATION. The authorized representative in Taiwan is RECHI CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
5ec4b2ac2e400545d356b9ccf8070de6
Registration Details
Taiwan FDA Registration: 5ec4b2ac2e400545d356b9ccf8070de6
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

RAMP CK-MB Assay
TW: ๅ€ซๆ™ฎ่‚Œ้…ธ็ฃท้…ธๆฟ€้…ถMBๅŒๅŠŸ้…ถๆชข้ฉ—่ฉฆๅŠ‘็ต„
Risk Class 2
MD

Registration Details

5ec4b2ac2e400545d356b9ccf8070de6

Ministry of Health Medical Device Import No. 027925

DHA05602792500

Company Information

Product Details

This product is a quantitative immunochromolayer analysis method, which is an in vitro diagnostic product for detecting CK-MB concentration in EDTA whole blood, and needs to be used with RAMP Reader System or RAMP 200 System.

A Clinical chemistry and clinical toxicology

A1215 Creatine phosphocatalyzed?/creatine excitation or isomeric test system

Imported from abroad

Dates and Status

Dec 02, 2015

Dec 02, 2025